Company Filing History:
1 out of 97 
1 out of 3,684 
1 out of 2,538 Years Active: 2004-2015
Title: The Innovative Contributions of Russell DeOrazio
Introduction
Russell DeOrazio is a notable inventor based in Schenectady, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that impact neurotransmitter reuptake.
Latest Patents
DeOrazio holds two patents that showcase his innovative work. His latest patents include the development of 2,5-methano- and 2,5-ethano-tetrahydrobenzazepine derivatives, which are designed to block the reuptake of norepinephrine, dopamine, and serotonin. These compounds are represented by specific formulas where the carbon atom designated is in the R or S configuration when n is 1, with defined substituents X and R-R. Additionally, he has worked on cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists.
Career Highlights
Throughout his career, DeOrazio has been associated with prominent companies in the pharmaceutical industry. He has worked at Albany Molecular Research, Inc. and Bristol-Myers Squibb Company, where he has contributed to various research and development projects.
Collaborations
DeOrazio has collaborated with several professionals in his field, including Peter Guzzo and Shuang Liu. Their combined expertise has likely enhanced the quality and impact of their research endeavors.
Conclusion
Russell DeOrazio's work in developing innovative pharmaceutical compounds has made a significant impact on the field. His patents and collaborations reflect his dedication to advancing medical science and improving therapeutic options.